Annual Operating Expenses
$33.05 M
+$8.86 M+36.65%
December 31, 2023
Summary
- As of February 7, 2025, FENC annual total operating expenses is $33.05 million, with the most recent change of +$8.86 million (+36.65%) on December 31, 2023.
- During the last 3 years, FENC annual operating expenses has risen by +$15.00 million (+83.06%).
- FENC annual operating expenses is now at all-time high.
Performance
FENC Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$10.84 M
-$853.00 K-7.29%
September 30, 2024
Summary
- As of February 7, 2025, FENC quarterly total operating expenses is $10.84 million, with the most recent change of -$853.00 thousand (-7.29%) on September 30, 2024.
- Over the past year, FENC quarterly operating expenses has dropped by -$853.00 thousand (-7.29%).
- FENC quarterly operating expenses is now -7.29% below its all-time high of $11.69 million, reached on June 30, 2024.
Performance
FENC Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
FENC Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +36.6% | -7.3% |
3 y3 years | +83.1% | +56.6% |
5 y5 years | +217.5% | +56.6% |
FENC Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +91.9% | -7.3% | +205.1% |
5 y | 5-year | at high | +154.1% | -7.3% | +208.3% |
alltime | all time | at high | +1958.5% | -7.3% | +2335.1% |
Fennec Pharmaceuticals Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $10.84 M(-7.3%) |
Jun 2024 | - | $11.69 M(+5.3%) |
Mar 2024 | - | $11.10 M(+1.5%) |
Dec 2023 | $33.05 M(+36.6%) | $10.94 M(+50.4%) |
Sep 2023 | - | $7.27 M(-7.3%) |
Jun 2023 | - | $7.84 M(+13.3%) |
Mar 2023 | - | $6.92 M(-9.5%) |
Dec 2022 | $24.19 M(+40.4%) | $7.65 M(-3.9%) |
Sep 2022 | - | $7.96 M(+59.0%) |
Jun 2022 | - | $5.01 M(+41.0%) |
Mar 2022 | - | $3.55 M(-15.5%) |
Dec 2021 | $17.22 M(-4.6%) | $4.21 M(+0.8%) |
Sep 2021 | - | $4.17 M(+6.5%) |
Jun 2021 | - | $3.92 M(-20.4%) |
Mar 2021 | - | $4.92 M(+40.0%) |
Dec 2020 | $18.05 M(+38.8%) | $3.52 M(-40.0%) |
Sep 2020 | - | $5.86 M(+20.9%) |
Jun 2020 | - | $4.84 M(+26.3%) |
Mar 2020 | - | $3.83 M(+5.0%) |
Dec 2019 | $13.01 M(+25.0%) | $3.65 M(+96.1%) |
Sep 2019 | - | $1.86 M(-61.3%) |
Jun 2019 | - | $4.81 M(+79.6%) |
Mar 2019 | - | $2.68 M(-13.7%) |
Dec 2018 | $10.41 M(+49.7%) | $3.10 M(+9.0%) |
Sep 2018 | - | $2.85 M(+6.9%) |
Jun 2018 | - | $2.67 M(+48.8%) |
Mar 2018 | - | $1.79 M(-28.8%) |
Dec 2017 | $6.95 M(+142.1%) | $2.52 M(+15.1%) |
Sep 2017 | - | $2.19 M(+47.8%) |
Jun 2017 | - | $1.48 M(+91.8%) |
Mar 2017 | - | $771.00 K(-32.7%) |
Dec 2016 | $2.87 M(+51.9%) | $1.15 M(+103.2%) |
Sep 2016 | - | $564.00 K(-20.2%) |
Jun 2016 | - | $707.00 K(+55.7%) |
Mar 2016 | - | $454.00 K(-17.6%) |
Dec 2015 | $1.89 M(-34.3%) | $551.00 K(+63.0%) |
Sep 2015 | - | $338.00 K(-38.4%) |
Jun 2015 | - | $549.00 K(+21.5%) |
Mar 2015 | - | $452.00 K(-42.9%) |
Dec 2014 | $2.88 M(+49.0%) | $791.00 K(+27.8%) |
Sep 2014 | - | $619.00 K(-33.4%) |
Jun 2014 | - | $930.00 K(+73.2%) |
Mar 2014 | - | $537.00 K(+29.1%) |
Dec 2013 | $1.93 M(-46.7%) | $416.00 K(+715.7%) |
Sep 2013 | - | $51.00 K(-94.5%) |
Jun 2013 | - | $927.00 K(+72.6%) |
Mar 2013 | - | $537.00 K(-52.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | $3.62 M(+5.3%) | $1.12 M(+78.3%) |
Sep 2012 | - | $630.00 K(-49.6%) |
Jun 2012 | - | $1.25 M(+102.9%) |
Mar 2012 | - | $616.00 K(-31.7%) |
Dec 2011 | $3.44 M(-25.3%) | $902.00 K(-4.4%) |
Sep 2011 | - | $944.00 K(+65.0%) |
Jun 2011 | - | $572.00 K(-44.0%) |
Mar 2011 | - | $1.02 M(+25.1%) |
Dec 2010 | $4.60 M(+62.7%) | $816.00 K(-11.0%) |
Sep 2010 | - | $917.00 K(-63.4%) |
Jun 2010 | - | $2.50 M(+584.4%) |
Mar 2010 | - | $366.00 K(-175.5%) |
Dec 2009 | $2.83 M(-79.6%) | -$485.00 K(-755.4%) |
Sep 2009 | - | $74.00 K(-92.3%) |
Jun 2009 | - | $961.00 K(-50.8%) |
Mar 2009 | - | $1.95 M(-26.1%) |
Dec 2008 | $13.89 M(-2.1%) | $2.64 M(-20.0%) |
Sep 2008 | - | $3.30 M(-6.0%) |
Jun 2008 | - | $3.51 M(-20.9%) |
Mar 2008 | - | $4.44 M(+39.5%) |
Dec 2007 | $14.19 M(-25.6%) | $3.18 M(-8.0%) |
Sep 2007 | - | $3.46 M(+0.5%) |
Jun 2007 | - | $3.44 M(-16.4%) |
Mar 2007 | - | $4.12 M(-41.3%) |
Dec 2006 | $19.06 M(+3.9%) | $7.01 M(+46.9%) |
Sep 2006 | - | $4.77 M(+19.9%) |
Jun 2006 | - | $3.98 M(+20.3%) |
Mar 2006 | - | $3.31 M(-36.3%) |
Dec 2005 | $18.35 M(+94.7%) | $5.19 M(+8.1%) |
Sep 2005 | - | $4.80 M(-2.8%) |
Jun 2005 | - | $4.94 M(+44.6%) |
Mar 2005 | - | $3.42 M(+8.2%) |
Sep 2004 | - | $3.16 M(+8.7%) |
Jun 2004 | $9.42 M(+39.9%) | $2.91 M(+7.3%) |
Mar 2004 | - | $2.71 M(+25.4%) |
Dec 2003 | - | $2.16 M(+31.9%) |
Sep 2003 | - | $1.64 M(-29.8%) |
Jun 2003 | $6.73 M(+66.6%) | $2.33 M(+22.9%) |
Mar 2003 | - | $1.90 M(+61.4%) |
Dec 2002 | - | $1.18 M(+2.7%) |
Sep 2002 | - | $1.15 M(-23.2%) |
Jun 2002 | $4.04 M(+49.4%) | $1.49 M(+64.1%) |
Mar 2002 | - | $909.60 K(+30.8%) |
Dec 2001 | - | $695.30 K(-27.1%) |
Sep 2001 | - | $953.30 K(+70.6%) |
Jun 2001 | $2.70 M(+68.4%) | - |
Dec 2000 | - | $558.80 K |
Jun 2000 | $1.61 M | - |
FAQ
- What is Fennec Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual operating expenses year-on-year change?
- What is Fennec Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly operating expenses year-on-year change?
What is Fennec Pharmaceuticals annual total operating expenses?
The current annual operating expenses of FENC is $33.05 M
What is the all time high annual operating expenses for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual total operating expenses is $33.05 M
What is Fennec Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, FENC annual total operating expenses has changed by +$8.86 M (+36.65%)
What is Fennec Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of FENC is $10.84 M
What is the all time high quarterly operating expenses for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly total operating expenses is $11.69 M
What is Fennec Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, FENC quarterly total operating expenses has changed by -$853.00 K (-7.29%)